Ameritas Investment Partners, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ameritas Investment Partners, Inc.

  • $2.84 Billion
  • Q2 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$144.95 - $152.29 $30,294 - $31,828
209 Added 4.47%
4,881 $737,000
Q2 2022

Aug 12, 2022
BUY
$83.14 - $145.99 $26,687 - $46,862
321 Added 7.38%
4,672 $680,000
Q3 2021

Nov 15, 2021
BUY
$98.85 - $138.91 $11,367 - $15,974
115 Added 2.71%
4,351 $604,000
Q2 2021

Aug 06, 2021
BUY
$65.78 - $105.02 $13,550 - $21,634
206 Added 5.11%
4,236 $411,000
Q4 2020

Feb 12, 2021
SELL
$65.07 - $98.24 $8,979 - $13,557
-138 Reduced 3.31%
4,030 $345,000
Q2 2020

Aug 05, 2020
BUY
$29.01 - $74.23 $20,539 - $52,554
708 Added 20.46%
4,168 $305,000
Q4 2019

Feb 13, 2020
BUY
$40.86 - $57.65 $8,498 - $11,991
208 Added 6.4%
3,460 $188,000
Q3 2019

Nov 14, 2019
BUY
$37.38 - $49.47 $15,624 - $20,678
418 Added 14.75%
3,252 $136,000
Q2 2019

Aug 14, 2019
BUY
$39.79 - $67.01 $10,265 - $17,288
258 Added 10.02%
2,834 $124,000
Q1 2019

May 15, 2019
BUY
$34.52 - $53.29 $8,526 - $13,162
247 Added 10.61%
2,576 $133,000
Q2 2018

Aug 13, 2018
SELL
$23.62 - $42.29 $8,337 - $14,928
-353 Reduced 13.16%
2,329 $92,000
Q1 2018

May 15, 2018
BUY
$22.49 - $34.56 $40,571 - $62,346
1,804 Added 205.47%
2,682 $69,000
Q2 2017

Aug 15, 2017
BUY
N/A
878
878 $22,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email